220 related articles for article (PubMed ID: 17088404)
1. Modifying muscle mass - the endocrine perspective.
Solomon AM; Bouloux PM
J Endocrinol; 2006 Nov; 191(2):349-60. PubMed ID: 17088404
[TBL] [Abstract][Full Text] [Related]
2. Prolonged absence of myostatin reduces sarcopenia.
Siriett V; Platt L; Salerno MS; Ling N; Kambadur R; Sharma M
J Cell Physiol; 2006 Dec; 209(3):866-73. PubMed ID: 16972257
[TBL] [Abstract][Full Text] [Related]
3. Targeting myostatin for therapies against muscle-wasting disorders.
Tsuchida K
Curr Opin Drug Discov Devel; 2008 Jul; 11(4):487-94. PubMed ID: 18600566
[TBL] [Abstract][Full Text] [Related]
4. Myostatin and its precursor protein are increased in the skeletal muscle of patients with Type-II muscle fibre atrophy.
Wójcik S; Nogalska A; Engel WK; Askanas V
Folia Morphol (Warsz); 2008 Feb; 67(1):6-12. PubMed ID: 18335407
[TBL] [Abstract][Full Text] [Related]
5. Sarcopenia--a critical perspective.
Hepple RT
Sci Aging Knowledge Environ; 2003 Nov; 2003(46):pe31. PubMed ID: 14627844
[TBL] [Abstract][Full Text] [Related]
6. The possible role of myostatin in skeletal muscle atrophy and cachexia.
Jespersen J; Kjaer M; Schjerling P
Scand J Med Sci Sports; 2006 Apr; 16(2):74-82. PubMed ID: 16533345
[TBL] [Abstract][Full Text] [Related]
7. The myostatin gene: physiology and pharmacological relevance.
Joulia-Ekaza D; Cabello G
Curr Opin Pharmacol; 2007 Jun; 7(3):310-5. PubMed ID: 17374508
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory factors in age-related muscle wasting.
Roth SM; Metter EJ; Ling S; Ferrucci L
Curr Opin Rheumatol; 2006 Nov; 18(6):625-30. PubMed ID: 17053510
[TBL] [Abstract][Full Text] [Related]
9. Resistance training, and IGF involvement in the maintenance of muscle mass during the aging process.
Adamo ML; Farrar RP
Ageing Res Rev; 2006 Aug; 5(3):310-31. PubMed ID: 16949353
[TBL] [Abstract][Full Text] [Related]
10. Myostatin expression during human muscle hypertrophy and subsequent atrophy: increased myostatin with detraining.
Jespersen JG; Nedergaard A; Andersen LL; Schjerling P; Andersen JL
Scand J Med Sci Sports; 2011 Apr; 21(2):215-23. PubMed ID: 19903317
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy with anabolic growth factors to prevent muscle atrophy.
Schakman O; Thissen JP
Curr Opin Clin Nutr Metab Care; 2006 May; 9(3):207-13. PubMed ID: 16607118
[TBL] [Abstract][Full Text] [Related]
12. Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness.
Ryall JG; Schertzer JD; Lynch GS
Biogerontology; 2008 Aug; 9(4):213-28. PubMed ID: 18299960
[TBL] [Abstract][Full Text] [Related]
13. Powerful signals for weak muscles.
Saini A; Faulkner S; Al-Shanti N; Stewart C
Ageing Res Rev; 2009 Oct; 8(4):251-67. PubMed ID: 19716529
[TBL] [Abstract][Full Text] [Related]
14. [Age-related muscle mass loss].
Czarkowska-Paczek B; Milczarczyk S
Przegl Lek; 2006; 63(8):658-61. PubMed ID: 17441378
[TBL] [Abstract][Full Text] [Related]
15. Tackling Australia's future health problems: developing strategies to combat sarcopenia--age-related muscle wasting and weakness.
Lynch GS
Intern Med J; 2004 May; 34(5):294-6. PubMed ID: 15151679
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle apoptosis, sarcopenia and frailty at old age.
Marzetti E; Leeuwenburgh C
Exp Gerontol; 2006 Dec; 41(12):1234-8. PubMed ID: 17052879
[TBL] [Abstract][Full Text] [Related]
17. Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin.
Gilson H; Schakman O; Kalista S; Lause P; Tsuchida K; Thissen JP
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E157-64. PubMed ID: 19435857
[TBL] [Abstract][Full Text] [Related]
18. Time-dependent expression of myostatin RNA transcript and protein in gastrocnemius muscle of mice after sciatic nerve resection.
Shao C; Liu M; Wu X; Ding F
Microsurgery; 2007; 27(5):487-93. PubMed ID: 17596894
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor alpha signaling in skeletal muscle: effects of age and caloric restriction.
Dirks AJ; Leeuwenburgh C
J Nutr Biochem; 2006 Aug; 17(8):501-8. PubMed ID: 16517142
[TBL] [Abstract][Full Text] [Related]
20. Role of IGF-I in skeletal muscle mass maintenance.
Clemmons DR
Trends Endocrinol Metab; 2009 Sep; 20(7):349-56. PubMed ID: 19729319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
